Alerts will be sent to your verified email
Verify Email
3BBLACKBIO
|
3B Blackbio Dx
|
TTK Healthcare
|
Nureca Ltd.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
31.8 % | 21.89 % | 9.17 % |
|
5yr Avg Net Profit Margin
|
40.4 % | 24.69 % | 6.15 % |
|
Price to Book
|
4.52 | 1.53 | 1.25 |
|
P/E
|
24.76 | 25.89 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
152.2 Days | -18.91 Days | 81.78 Days |
|
5yr Average Interest Coverage Ratio
|
328.3 | 20.16 | 19.65 |
|
5yr Avg ROCE
|
38.24 % | 7.51 % | 12.65 % |
|
5yr Avg Operating Profit Margin
|
47.2 % | 4.27 % | 3.76 % |
|
5 yr average Debt to Equity
|
0.03 | 0.04 | 0.0 |
|
5yr CAGR Net Profit
|
33.12 % | 11.95 % | -55.06 % |
|
5yr Average Return on Assets
|
23.56 % | 16.71 % | 7.53 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
41.28 % | 74.56 % | 64.33 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
2.85 % | 0.0 | -5.67 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -2.46 % | -1.35 % |
|
3B Blackbio Dx
|
TTK Healthcare
|
Nureca Ltd.
|
|---|